PMC:7796052 / 11277-11487 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"308","span":{"begin":147,"end":149},"obj":"Gene"},{"id":"311","span":{"begin":80,"end":82},"obj":"Gene"},{"id":"312","span":{"begin":187,"end":195},"obj":"Species"},{"id":"316","span":{"begin":178,"end":186},"obj":"Disease"}],"attributes":[{"id":"A308","pred":"tao:has_database_id","subj":"308","obj":"Gene:3827"},{"id":"A311","pred":"tao:has_database_id","subj":"311","obj":"Gene:3827"},{"id":"A312","pred":"tao:has_database_id","subj":"312","obj":"Tax:9606"},{"id":"A316","pred":"tao:has_database_id","subj":"316","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"As shown in the present communication, its pharmacological profile as a partial BK B2 agonist is expected to antagonize the inflammatory action of BK, shown to be upregulated in Covid-19 patients [12,13,14,15]."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T72","span":{"begin":0,"end":210},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"As shown in the present communication, its pharmacological profile as a partial BK B2 agonist is expected to antagonize the inflammatory action of BK, shown to be upregulated in Covid-19 patients [12,13,14,15]."}